Logo image of FRPT

FRESHPET INC (FRPT) Stock Fundamental Analysis

NASDAQ:FRPT - Nasdaq - US3580391056 - Common Stock - Currency: USD

70.82  -1.13 (-1.57%)

After market: 70.82 0 (0%)

Fundamental Rating

4

Overall FRPT gets a fundamental rating of 4 out of 10. We evaluated FRPT against 91 industry peers in the Food Products industry. While FRPT seems to be doing ok healthwise, there are quite some concerns on its profitability. FRPT shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year FRPT was profitable.
FRPT had a positive operating cash flow in the past year.
FRPT had negative earnings in 4 of the past 5 years.
Of the past 5 years FRPT 4 years had a positive operating cash flow.
FRPT Yearly Net Income VS EBIT VS OCF VS FCFFRPT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M -300M

1.2 Ratios

FRPT has a Return On Assets of 1.00%. This is comparable to the rest of the industry: FRPT outperforms 40.66% of its industry peers.
FRPT has a worse Return On Equity (1.49%) than 60.44% of its industry peers.
FRPT has a Return On Invested Capital (1.94%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA 1%
ROE 1.49%
ROIC 1.94%
ROA(3y)-1.53%
ROA(5y)-1.83%
ROE(3y)-1.62%
ROE(5y)-1.96%
ROIC(3y)N/A
ROIC(5y)N/A
FRPT Yearly ROA, ROE, ROICFRPT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 -2 4 -4

1.3 Margins

FRPT has a Profit Margin of 1.54%. This is comparable to the rest of the industry: FRPT outperforms 43.96% of its industry peers.
FRPT has a Operating Margin (3.58%) which is comparable to the rest of the industry.
Looking at the Gross Margin, with a value of 40.63%, FRPT belongs to the top of the industry, outperforming 91.21% of the companies in the same industry.
FRPT's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 3.58%
PM (TTM) 1.54%
GM 40.63%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.84%
GM growth 5Y-2.62%
FRPT Yearly Profit, Operating, Gross MarginsFRPT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

More info and screens

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), FRPT is destroying value.
FRPT has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, FRPT has more shares outstanding
Compared to 1 year ago, FRPT has an improved debt to assets ratio.
FRPT Yearly Shares OutstandingFRPT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
FRPT Yearly Total Debt VS Total AssetsFRPT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

An Altman-Z score of 4.78 indicates that FRPT is not in any danger for bankruptcy at the moment.
FRPT has a Altman-Z score of 4.78. This is amongst the best in the industry. FRPT outperforms 84.62% of its industry peers.
A Debt/Equity ratio of 0.41 indicates that FRPT is not too dependend on debt financing.
FRPT has a Debt to Equity ratio of 0.41. This is comparable to the rest of the industry: FRPT outperforms 54.95% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.41
Debt/FCF N/A
Altman-Z 4.78
ROIC/WACC0.23
WACC8.3%
FRPT Yearly LT Debt VS Equity VS FCFFRPT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 4.91 indicates that FRPT has no problem at all paying its short term obligations.
FRPT has a Current ratio of 4.91. This is amongst the best in the industry. FRPT outperforms 94.51% of its industry peers.
A Quick Ratio of 3.92 indicates that FRPT has no problem at all paying its short term obligations.
FRPT has a Quick ratio of 3.92. This is amongst the best in the industry. FRPT outperforms 95.60% of its industry peers.
Industry RankSector Rank
Current Ratio 4.91
Quick Ratio 3.92
FRPT Yearly Current Assets VS Current LiabilitesFRPT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

7

3. Growth

3.1 Past

FRPT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 266.67%, which is quite impressive.
FRPT shows a strong growth in Revenue. In the last year, the Revenue has grown by 23.25%.
Measured over the past years, FRPT shows a very strong growth in Revenue. The Revenue has been growing by 31.72% on average per year.
EPS 1Y (TTM)266.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-75.68%
Revenue 1Y (TTM)23.25%
Revenue growth 3Y31.84%
Revenue growth 5Y31.72%
Sales Q2Q%17.6%

3.2 Future

The Earnings Per Share is expected to grow by 38.52% on average over the next years. This is a very strong growth
FRPT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 18.38% yearly.
EPS Next Y33.71%
EPS Next 2Y50.67%
EPS Next 3Y45.41%
EPS Next 5Y38.52%
Revenue Next Year15.62%
Revenue Next 2Y16.96%
Revenue Next 3Y17.95%
Revenue Next 5Y18.38%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
FRPT Yearly Revenue VS EstimatesFRPT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 1B 2B 3B
FRPT Yearly EPS VS EstimatesFRPT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 2 4 6 8 10

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 107.30, the valuation of FRPT can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of FRPT is on the same level as its industry peers.
FRPT's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.50.
Based on the Price/Forward Earnings ratio of 33.19, the valuation of FRPT can be described as expensive.
The rest of the industry has a similar Price/Forward Earnings ratio as FRPT.
When comparing the Price/Forward Earnings ratio of FRPT to the average of the S&P500 Index (36.44), we can say FRPT is valued inline with the index average.
Industry RankSector Rank
PE 107.3
Fwd PE 33.19
FRPT Price Earnings VS Forward Price EarningsFRPT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of FRPT indicates a slightly more expensive valuation: FRPT is more expensive than 62.64% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 31.41
FRPT Per share dataFRPT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates FRPT does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as FRPT's earnings are expected to grow with 45.41% in the coming years.
PEG (NY)3.18
PEG (5Y)N/A
EPS Next 2Y50.67%
EPS Next 3Y45.41%

More info and screens

0

5. Dividend

5.1 Amount

FRPT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

FRESHPET INC

NASDAQ:FRPT (7/18/2025, 8:00:01 PM)

After market: 70.82 0 (0%)

70.82

-1.13 (-1.57%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)05-05 2025-05-05/bmo
Earnings (Next)08-04 2025-08-04/bmo
Inst Owners121.74%
Inst Owner Change0.03%
Ins Owners1.67%
Ins Owner Change5.84%
Market Cap3.45B
Analysts80.83
Price Target107.5 (51.79%)
Short Float %16.08%
Short Ratio5.88
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-5.34%
Min EPS beat(2)-8.85%
Max EPS beat(2)-1.83%
EPS beat(4)2
Avg EPS beat(4)36.84%
Min EPS beat(4)-8.85%
Max EPS beat(4)120.73%
EPS beat(8)6
Avg EPS beat(8)113.89%
EPS beat(12)7
Avg EPS beat(12)57.13%
EPS beat(16)7
Avg EPS beat(16)12.47%
Revenue beat(2)0
Avg Revenue beat(2)-1.63%
Min Revenue beat(2)-2.49%
Max Revenue beat(2)-0.78%
Revenue beat(4)1
Avg Revenue beat(4)-0.84%
Min Revenue beat(4)-2.49%
Max Revenue beat(4)0.07%
Revenue beat(8)4
Avg Revenue beat(8)-0.05%
Revenue beat(12)6
Avg Revenue beat(12)0.18%
Revenue beat(16)8
Avg Revenue beat(16)-0.39%
PT rev (1m)-9.06%
PT rev (3m)-27.27%
EPS NQ rev (1m)-30.77%
EPS NQ rev (3m)-48.18%
EPS NY rev (1m)-0.45%
EPS NY rev (3m)-5.73%
Revenue NQ rev (1m)0.01%
Revenue NQ rev (3m)-4.72%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4.48%
Valuation
Industry RankSector Rank
PE 107.3
Fwd PE 33.19
P/S 3.4
P/FCF N/A
P/OCF 22.48
P/B 3.29
P/tB 3.29
EV/EBITDA 31.41
EPS(TTM)0.66
EY0.93%
EPS(NY)2.13
Fwd EY3.01%
FCF(TTM)-0.28
FCFYN/A
OCF(TTM)3.15
OCFY4.45%
SpS20.8
BVpS21.51
TBVpS21.51
PEG (NY)3.18
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1%
ROE 1.49%
ROCE 2.46%
ROIC 1.94%
ROICexc 2.32%
ROICexgc 2.32%
OM 3.58%
PM (TTM) 1.54%
GM 40.63%
FCFM N/A
ROA(3y)-1.53%
ROA(5y)-1.83%
ROE(3y)-1.62%
ROE(5y)-1.96%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.84%
GM growth 5Y-2.62%
F-Score7
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 0.41
Debt/FCF N/A
Debt/EBITDA 3.67
Cap/Depr 210.1%
Cap/Sales 16.47%
Interest Coverage 3.82
Cash Conversion 132.7%
Profit Quality N/A
Current Ratio 4.91
Quick Ratio 3.92
Altman-Z 4.78
F-Score7
WACC8.3%
ROIC/WACC0.23
Cap/Depr(3y)442.82%
Cap/Depr(5y)604.48%
Cap/Sales(3y)29.67%
Cap/Sales(5y)41.38%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)266.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-75.68%
EPS Next Y33.71%
EPS Next 2Y50.67%
EPS Next 3Y45.41%
EPS Next 5Y38.52%
Revenue 1Y (TTM)23.25%
Revenue growth 3Y31.84%
Revenue growth 5Y31.72%
Sales Q2Q%17.6%
Revenue Next Year15.62%
Revenue Next 2Y16.96%
Revenue Next 3Y17.95%
Revenue Next 5Y18.38%
EBIT growth 1Y2032.45%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year390.83%
EBIT Next 3Y101.99%
EBIT Next 5Y66.75%
FCF growth 1Y94.72%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y792.92%
OCF growth 3Y519.17%
OCF growth 5Y56.72%